RareX Limited (ASX:REE)

RareX Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cost of Revenue	1.63	1.46	1.3	1.5	2.77
Gross Profit	-1.63	-1.46	-1.3	-1.5	-2.77
Selling, General & Admin	0.99	0.97	1.31	1.38	0.84
Other Operating Expenses	-0.98	-2.02	-2.17	-0.87	-
Operating Expenses	1.14	2.61	7.74	9.07	3.26
Operating Income	-2.77	-4.07	-9.04	-10.57	-6.04
Interest Expense	-0	-0.01	-0.02	-0.02	-0.01
Interest & Investment Income	0.03	0.06	0.01	0	0.01
Earnings From Equity Investments	-0.41	-0.56	-0.56	-0.47	-
Currency Exchange Gain (Loss)	0.01	0	0	-0	-0
Other Non Operating Income (Expenses)	-	-	0.29	0.04	0.05
EBT Excluding Unusual Items	-3.14	-4.58	-9.32	-11.02	-5.99
Gain (Loss) on Sale of Investments	-0.36	1.3	-	-2.54	0.6
Gain (Loss) on Sale of Assets	-	-	-	2.33	-
Pretax Income	-3.5	-3.28	-9.32	-11.23	-5.39
Net Income	-3.5	-3.28	-9.32	-11.23	-5.39
Net Income to Common	-3.5	-3.28	-9.32	-11.23	-5.39
Shares Outstanding (Basic)	810	698	606	484	406
Shares Outstanding (Diluted)	810	698	606	484	406
Shares Change (YoY)	16.07%	15.13%	25.20%	19.22%	50.45%
EPS (Basic)	-0.00	-0.00	-0.02	-0.02	-0.01
EPS (Diluted)	-0.00	-0.00	-0.02	-0.02	-0.01
Free Cash Flow	-2.71	-4.18	-7.58	-6.54	-5.95
Free Cash Flow Per Share	-0.00	-0.01	-0.01	-0.01	-0.01
EBITDA	-2.7	-3.99	-8.99	-10.54	-6.01
D&A For EBITDA	0.07	0.07	0.05	0.03	0.02
EBIT	-2.77	-4.07	-9.04	-10.57	-6.04
Revenue as Reported	-	-	2.18	3.25	0.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.